Cantargia AB (CHIX:CANTAS) Days Payable: 0.00 (As of Mar. 2026)

What is Cantargia AB Days Payable?

Cantargia AB CHIX:CANTAS 37 Days Payable is 0.00 as of Mar. 2026. GuruFocus rates CHIX:CANTAS with a GF Score™ of 37/100. The stock has 2 warning signs investors should review. Among 705 Biotechnology companies, Cantargia AB ranks worse than 141843.83% on this metric.

Cantargia AB's average Accounts Payable for the three months ended in Mar. 2026 was kr6.4 Mil. Cantargia AB's Cost of Goods Sold for the three months ended in Mar. 2026 was kr0.0 Mil.

The historical rank and industry rank for Cantargia AB's Days Payable or its related term are showing as below:

CHIX:CANTAs's Days Payable is not ranked ^*
in the Biotechnology industry.
Industry Median: 113.36
* Ranked among companies with meaningful Days Payable only.

Cantargia AB's Days Payable stayed the same from Mar. 2025 (0.00) to Mar. 2026 (0.00). stayed the same

Cantargia AB Days Payable Related Terms

Cantargia AB Days Payable Historical Data

* Premium members only.

The historical data trend for Cantargia AB's Days Payable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Cantargia AB Days Payable Chart

Cantargia AB Annual Data

Trend

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Dec25

Days Payable

Get a 7-Day Free Trial

0.00

Cantargia AB Quarterly Data
	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25	Jun25	Sep25	Dec25	Mar26
Days Payable	Get a 7-Day Free Trial															0.00	0.00	0.00	0.00	0.00

CHIX:CANTAS vs VRTX, REGN, ALNY: Days Payable Comparison

For the Biotechnology subindustry, Cantargia AB's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Cantargia AB Days Payable vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Cantargia AB's Days Payable distribution charts can be found below:

* The bar in red indicates where Cantargia AB's Days Payable falls into.

Save Embed

37GF Score

Cantargia AB CHIX:CANTAS

Days Payable is just one metric. See GF Score™, valuation, warning signs, and more.

View Full Analysis

Cantargia AB Days Payable Calculation

Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.

Cantargia AB's Days Payable for the fiscal year that ended in Dec. 2025 is calculated as

	Days Payable (A: Dec. 2025 )
=	Average Accounts Payable					/	Cost of Goods Sold	*	Days in Period
=	( (Accounts Payable (A: Dec. 2024 )	+	Accounts Payable (A: Dec. 2025 ))	/	count )	/	Cost of Goods Sold (A: Dec. 2025 )	*	Days in Period
=	( (10.984	+	5.971)	/	2 )	/	0	*	365
=	8.4775					/	0	*	365
=	N/A

Cantargia AB's Days Payable for the quarter that ended in Mar. 2026 is calculated as:

	Days Payable (Q: Mar. 2026 )
=	Average Accounts Payable					/	Cost of Goods Sold	*	Days in Period
=	( (Accounts Payable (Q: Dec. 2025 )	+	Accounts Payable (Q: Mar. 2026 ))	/	count )	/	Cost of Goods Sold (Q: Mar. 2026 )	*	Days in Period
=	( (5.971	+	6.734)	/	2 )	/	0	*	365 / 4
=	6.3525					/	0	*	365 / 4
=	N/A

Frequently Asked Questions Learn more about Days Payable →

What does a Days Payable of 0.00 mean?

Cantargia AB (CHIX:CANTAS) has a Days Payable of 0.00 as of Mar. 2026. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Cantargia AB and its competitors. According to the industry distribution chart, Cantargia AB ranks #999999 out of 705 companies in the Biotechnology industry.

Is Cantargia AB's Days Payable too high?

Cantargia AB's current Days Payable is 0.00. Based on the distribution chart, Cantargia AB ranks #999999 out of 705 companies in the Biotechnology industry, which is in the bottom quartile relative to peers. Overall, Cantargia AB has a GF Score™ of 37/100, reflecting its overall financial health beyond just this single metric.

How does Cantargia AB's Days Payable compare to VRTX and REGN?

According to the Biotechnology industry distribution chart, Cantargia AB ranks #999999 out of 705 companies for Days Payable. This places Cantargia AB in the lower half of its industry. The industry median Days Payable is 113.36. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.

What is a good Days Payable for a Biotechnology company?

The median Days Payable among Biotechnology companies is 113.36, based on 705 companies in the industry. Companies in the top quartile (top 25%) have a Days Payable significantly above this median, while those in the bottom quartile fall well below. However, Days Payable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.

What does a high Days Payable mean?

A high Days Payable can signal that a stock is expensive relative to its fundamentals. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Cantargia AB and its competitors. For the Biotechnology industry, the median Days Payable is 113.36 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Cantargia AB's current Days Payable is 0.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.

Is Cantargia AB stock overvalued right now?

Cantargia AB (CHIX:CANTAS) has a current Days Payable of 0.00. The current Days Payable is 0.00. Cantargia AB's overall GF Score™ is 37/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.

How is Days Payable calculated?

Days Payable is calculated from a company's financial statements. For Cantargia AB (CHIX:CANTAS), the current Days Payable is 0.00 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Cantargia AB Business Description

Industry Healthcare Biotechnology

Comparable Companies OSTO:ALZCUR XSAT:CESSA OSTO:SPRINT OSTO:CLBIO OSTO:IVACC OSTO:ONCO OSTO:ACE OSTO:FLUO OSTO:IMMU OSTO:XSPRAY VRTX REGN XBRU:UCB XBRU:ARGX XKRX:207940 ALNY ASX:CSL RVMD ONC MRNA

Other Exchanges CANTA:Sweden 7V3:Germany

Address Scheelevagen 27, Lund, SWE, 223 63

Website https://www.cantargia.com

Cantargia AB is a Swedish biotech company that develops targeted antibody-based drugs for cancer as well as autoimmune and inflammatory diseases. It has developed specific antibodies against IL1RAP to treat serious, life-threatening diseases. The company's development programme includes the candidate drugs nadunolimab (CAN04) and CAN10, both in the clinical development stage, which were latter acquired by Otsuka Pharmaceutical in 2025. In addition, the company is also developing a a pre-clinical project CAN14, derived from antibody platform CANxx. Geographically, the company's revenues have been generated in the markets of Japan and United States.

37GF Score

Get the complete analysis for CHIX:CANTAS

Days Payable is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

kr4.17

Price

View CHIX:CANTAS Analysis

See Days Payable data for all stocks →